3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Carcinoma, Hepatocellular
46
Liver Neoplasms
9
Neoplasm Metastasis
4
Leukemia, Myeloid, Acute
4
Pancreatic Neoplasms
3
Melanoma
3
Carcinoma, Renal Cell
3
Sarcoma
2
Recurrence
2
Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma
2
Breast Neoplasms
2
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Relapsed Pediatric Solid Tumor
1
Portal Vein Tumor Thrombus
1
Neoplasms, Glandular and Epithelial
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Mesothelioma
1
Lung Neoplasms
1
Liver Diseases
1
Leukemia, Monocytic, Acute
1
Kidney Neoplasms
1
Hemangiosarcoma
1
HCC
1
Gastrointestinal Neoplasms
1
Interventions
Ipilimumab
3
Triamcinolone Acetonide
2
Ranibizumab
2
Nivolumab
2
Amplified Fragment Length Polymorphism Analysis
2
treosulfan
1
salicylhydroxamic acid
1
aldesleukin
1
Ultrasonography
1
Tramadol
1
Temozolomide
1
Tamoxifen
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Sunitinib
1
Sorafenib
1
Rose Bengal
1
Radiosurgery
1
Physical Examination
1
Pharmacogenomic Testing
1
Interviews as Topic
1
Immunotherapy
1
Ibuprofen
1
Gemcitabine
1
Eye Enucleation
1
Cyclophosphamide
1
Cisplatin
1
Chemotherapy, Adjuvant
1
CTLA-4 Antigen
1
Brachytherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Uveal Melanoma
×
Sorafenib
×
Clear all
NCT01377025
2014-12-03
STREAM
University Hospital, Essen
Phase 2
Unknown
200 enrolled